Abstract
G protein-coupled receptors (GPCRs) transduce signals from a wide variety of extracellular stimuli such as ions, photons, odors, tastants, hormones, and neurotransmitters and hence are central players in communication between the cells of multicellular organisms and their environment. Characterization of these receptors at the molecular level has shown that GPCRs form dimers or oligomers (for simplicity, herein called dimers), yet their function is just beginning to emerge. The activation of GPCRs as dimers presents the opportunity for trans-activation of receptors, where a ligand-bound GPCR can change the activity of a neighboring GPCR. Trans-activation of GPCRs can take place either via transmembrane domains (TMDs) of two or more receptors or through a ligand-bound extracellular domain (ECD) of one receptor to the TMD of another (referred to as intermolecular cooperation), for GPCRs with a distinct ligand-binding ECD such as the glycoprotein hormone receptors. Before explaining the phenomenon of intermolecular cooperation between domains of GPCR dimers, this chapter first discusses the molecular interactions between GPCR dimers, which leads to trans-activation, and then explains various experimental strategies employed to study the significance of intermolecular cooperation either in rescuing the signaling of mutant GPCRs by complementary receptors or in changing the allosteric properties of GPCR dimers. The physiological significance of intermolecular cooperation is also discussed in detail, as well as its clinical significance that lies in the use of agents that selectively activate or inhibit particular signaling pathways or affect GPCR dimer interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Drews J (2000) Drug discovery: a historical perspective. Science 287:1960–1964
Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
Venkatakrishnan AJ, Deupi X, Lebon G et al (2013) Molecular signatures of G-protein-coupled receptors. Nature 494:185–194
Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21–80
Birdsall NJM (1982) Can different receptors interact directly with each other? Trends Neurosci 5:137–138
Watanabe AM, McConnaughey MM, Strawbridge RA et al (1978) Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. J Biol Chem 253:4833–4836
Jones KA, Borowsky B, Tamm JA et al (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674–679
Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697–700
Daniels DJ, Lenard NR, Etienne CL et al (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 102:19208–19213
Palczewski K, Kumasaka T, Hori T et al (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739–745
Rasmussen SG, Choi HJ, Rosenbaum DM et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383–387
Haga K, Kruse AC, Asada H et al (2012) Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482:547–551
Kobilka BK, Kobilka TS, Daniel K et al (1988) Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240:1310–1316
Maggio R, Vogel Z, Wess J (1993) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular “cross-talk” between G-protein-linked receptors. Proc Natl Acad Sci U S A 90:3103–3107
Ji I, Lee C, Song Y et al (2002) Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol 16:1299–1308
Vassart G, Pardo L, Costagliola S (2004) A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29:119–126
Kleinau G, Krause G (2009) Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 30:133–151
Ji I, Lee C, Jeoung M et al (2004) Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. Mol Endocrinol 18:968–978
Romano C, Yang WL, O’Malley KL (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271:28612–28616
Bai M, Trivedi S, Brown EM (1998) Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 273:23605–23610
White JH, Wise A, Main MJ et al (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679–682
Robbins MJ, Calver AR, Filippov AK et al (2001) GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer. J Neurosci 21:8043–8052
James JR, Oliveira MI, Carmo AM (2006) A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 3:1001–1006
Bouvier M, Heveker N, Jockers R et al (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nat Methods 4:3–4
Salahpour A, Masri B (2007) Experimental challenge to a ‘rigorous’ BRET analysis of GPCR oligomerization. Nat Methods 4:599–600
Calebiro D, Rieken F, Wagner J et al (2013) Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci U S A 110:743–748
Kasai RS, Suzuki KG, Prossnitz ER (2011) Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging. J Cell Biol 192:463–480
Hern JA, Baig AH, Mashanov GI (2010) Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci U S A 107:2693–2698
Whorton MR, Bokoch MP, Rasmussen SG et al (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A 104:7682–7687
Ernst OP, Gramse V, Kolbe M et al (2007) Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci U S A 104:10859–10864
Lee C, Ji I, Ryu K et al (2002) Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem 277:15795–15800
Lee C, Ji IJ, Ji TH (2002) Use of defined-function mutants to access receptor-receptor interactions. Methods 27:318–323
Laue L, Wu SM, Kudo M et al (1995) A nonsense mutation of the human luteinizing-hormone receptor gene in Leydig-cell hypoplasia. Hum Mol Genet 4:1429–1433
Osuga Y, Hayashi M, Kudo M et al (1997) Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J Biol Chem 272:25006–25012
Guan R, Wu X, Feng X et al (2010) Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal 22:247–256
Harikumar KG, Lam PC, Dong M et al (2007) Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues. J Biol Chem 282:32834–32843
Allen MD, Neumann S, Gershengorn MC (2011) Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J 25:3687–3694
Karges B, Gidenne S, Aumas C et al (2005) Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation. Mol Endocrinol 19:2086–2098
Urizar E, Montanelli L, Loy T, Bonomi M et al (2005) Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24:1954–1964
Zoenen M, Urizar E, Swillens S et al (2012) Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers. Nat Commun 3:1007
Novi F, Stanasila L, Giorgi F et al (2005) Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. J Biol Chem 280:19768–19776
Rivero-Muller A, Chou YY, Ji I et al (2010) Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci U S A 107:2319–2324
Zhang Y, Buchholz F, Muyrers JP et al (1998) A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20:123–128
Ahtiainen P, Rulli S, Pakarainen T et al (2007) Phenotypic characterization of mice with exaggerated and missing LH/hCG action. Mol Cell Endocrinol 260–262:255–263
Zhang FP, Poutanen M, Wilbertz J et al (2001) Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:172–183
Abdelhamid EE, Sultana M, Portoghese PS (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258:299–303
Fundytus ME, Schiller PW, Shapiro M (1995) Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]. Eur J Pharmacol 286:105–108
Miyamoto Y, Portoghese PS, Takemori AE (1993) Involvement of delta 2 opioid receptors in the development of morphine dependence in mice. J Pharmacol Exp Ther 264:1141–1145
Gonzalez-Maeso J, Ang RL, Yuen T (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93–97
Sealfon SC, Gonzalez-Maeso J (2008) Receptor pair for schizophrenia. Pediatr Res 64:1
Schwenk J, Metz M, Zolles G (2010) Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465:231–235
AbdAlla S, Lother H, el Massiery A et al (2001) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7:1003–1009
Lain KY, Roberts JM (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287:3183–3186
Salahpour A, Angers S, Mercier JF (2004) Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390–33397
Lopez-Gimenez JF, Canals M, Pediani JD (2007) The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71:1015–1029
Canals M, Lopez-Gimenez JF, Milligan G (2009) Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem J 417:161–172
Kobayashi H, Ogawa K, Yao R (2009) Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 10:1019–1033
Ward NA, Hirst S, Williams J, Findlay JB (2012) Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles. Biochem Soc Trans 40:717–720
Rene P, Le Gouill C, Pogozheva ID et al (2010) Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. J Pharmacol Exp Ther 335:520–532
Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789
Sitia R, Braakman I (2003) Quality control in the endoplasmic reticulum protein factory. Nature 426:891–894
Huhtaniemi IT, Nevo N, Amsterdam A et al (1986) Effect of postnatal treatment with a gonadotropin-releasing hormone antagonist on sexual maturation of male rats. Biol Reprod 35:501–507
Catt KJ, Ketelslegers JM, Dufau ML (1976) In: Blecher M (ed) Methods in receptor research. Marcel Dekker, New York
Rivero-Muller A, Lajic S, Huhtaniemi I (2007) Assisted large fragment insertion by Red/ET-recombination (ALFIRE) – an alternative and enhanced method for large fragment recombineering. Nucleic Acids Res 35:e78
Van Keuren ML, Gavrilina GB, Filipiak WE et al (2009) Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes. Transgenic Res 18:769–785
Huang J, Chen S, Zhang JJ et al (2013) Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol 20:419–425
Acknowledgments
The authors declare no conflict of interest. Their work has been supported by the Academy of Finland, a Programme Grant from the Wellcome Trust, and a grant by the Biotechnology and Biological Sciences Research Council (UK).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Trehan, A., Jonas, K.C., Huhtaniemi, I., Hanyaloglu, A.C., Rivero-Müller, A. (2014). Rescue of Defective G Protein-Coupled Receptor Function by Intermolecular Cooperation. In: Stevens, C. (eds) G Protein-Coupled Receptor Genetics. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-779-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-62703-779-2_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-778-5
Online ISBN: 978-1-62703-779-2
eBook Packages: Springer Protocols